BRAF and thyroid cancer, nonmedullary, 2: Tumor histology was PTC in 73.2%, including infiltrative follicular variant PTC—tumors with BRAF p.V600E-like molecular profile according to current classification,22 encapsulated follicular variant PTC in 7.3%, FTC in 13.4%, and oncocytic thyroid carcinoma of follicular cells (OCC) in 6.1%.